Program Leader for Injury Prevention
Institute of Health and Biomedical Innovation
Professor Graham Kerr is Program Leader for Injury Prevention at the Institute of Health and Biomedical Innovation. He founded and leads the Movement Neuroscience group which has a significant focus on ageing and movement disorders, particularly in neurodegenerative diseases such as Parkinson’s disease, Multiple Sclerosis, Diabetes and tremor disorders. His research on Parkinson’s disease has resulted in papers on falls prediction (Neurology, 75(2): 116-124, 2010), effects of deep brain stimulation on gait (Brain, 135, 1446-1454, 2012) and tremor (Movement Disorders, 23(3): 386-394, 2008).
Methodologies include EEG, EMG, functional Near Infra-Red Spectroscopy (fNIRS), transcranial dopler, continuous blood pressure, ECG, transcranial magnetic (TMS) and direct current stimulation (tDCS) and neuromuscular electrical stimulation (NMES). These methods are utilised in conjunction with motion analysis using 3D motion capture and force plates during “real world” movement and locomotor tasks.
Current projects include:
- Corticomuscular interactions during natural overground locomotion;
- Cerebrovascular changes in Parkinson’s disease and associations with cognitive function and balance control;
- Neural responses to functional electrical stimulation of muscles;
- Effects of enhanced peripheral stimulation on balance and gait.
Left: Grand-average time-frequency coherence spectra of EEG and EMG during overground and treadmill walking. (LHS-left heel strike; RHS-right heel strike; LTO-left toe off; RTO-right toe off.)
Right: NIRS-SPM cortical activation maps for oxygenated haemoglobin (top row) and deoxygenated haemoglobin (bottom row) during voluntary (VOL) and NMES-evoked wrist movements (50%MTI) (PLoS ONE, 10(7):e0131951).